Latest filing published 31 Jul 2026 for Vericel Corp, €46k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Jonathan Siegal in Vericel Corp, where the filings describe the role as senior executive. In total, 24 filings cover trades dated from 30 September 2022 to 30 July 2026.
No open-market purchase appears, only 9 sales worth €434k. The rest of the record consists of 15 option exercises. 2026 to date brings no purchases and 4 sales.
The record was last updated on 31 July 2026 with an open-market sale (€107k) in Vericel Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
24 of 24 declarations